Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:13:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor metadata change and does not affect study content or results.
    Difference
    0.1%
    Check dated 2026-02-13T13:53:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The only change is a version update from v3.4.0 to v3.4.1; no study content, eligibility criteria, or results were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:21:10.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added UI controls for Show glossary and Hide glossary, and updated the page revision label to Revision: v3.4.0. Minor capitalization changes to 'Last Update Submitted' and 'No FEAR Act' text were applied.
    Difference
    0.4%
    Check dated 2026-01-22T17:38:57.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; this seems to be metadata/versioning information rather than a substantive change to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:44:59.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a dedicated 'Locations' section featuring the Colorado site. Removed the old 'Colorado Locations' entry and the 'HHS Vulnerability Disclosure' link from the footer.
    Difference
    0.2%
    Check dated 2025-12-17T20:17:39.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.